Handelsbanken Fonder AB’s Bristol-Myers Squibb Co Position
Does Handelsbanken Fonder AB own Bristol-Myers Squibb Co (BMY)? Yes — 1.36M shares worth $82M (+0.27% of its 13F portfolio) as of Q1 2026, up from 1.27M shares the prior filed quarter.
Position Value
$82M
Q1 2026
Shares
1.36M
% of Portfolio
+0.27%
Quarters Held
24
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.36M | $82M | +0.27% |
| Q4 2025 | 1.27M | $68M | +0.21% |
| Q3 2025 | 1.13M | $51M | +0.16% |
| Q2 2025 | 1.46M | $68M | +0.24% |
| Q1 2025 | 1.48M | $91M | +0.37% |
| Q4 2024 | 1.48M | $84M | +0.32% |
| Q3 2024 | 1.51M | $78M | +0.31% |
| Q2 2024 | 899.0K | $37M | +0.16% |
| Q1 2024 | 908.2K | $49M | +0.21% |
| Q4 2023 | 1.02M | $52M | +0.25% |
| Q3 2023 | 1.02M | $59M | +0.33% |
| Q2 2023 | 980.1K | $63M | +0.34% |
| Q1 2023 | 1.02M | $71M | +0.41% |
| Q4 2022 | 982.3K | $71M | +0.44% |
| Q3 2022 | 978.3K | $70M | +0.47% |
| Q2 2022 | 779.8K | $60M | +0.39% |
| Q1 2022 | 643.7K | $47M | +0.26% |
| Q4 2021 | 654.5K | $41M | +0.20% |
| Q3 2021 | 615.9K | $36M | +0.19% |
| Q2 2021 | 610.3K | $41M | +0.21% |
| Q1 2021 | 653.8K | $41M | +0.23% |
| Q4 2020 | 647.0K | $40M | +0.24% |
| Q3 2020 | 638.6K | $39M | +0.28% |
| Q2 2020 | 1.24M | $73M | +0.31% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of BMY.